Vaccination Controversy Raises Questions
The topic of vaccines is so contentious that the American Academy of Pediatrics recently faced criticism after boycotting a meeting chaired by the Advisory Committee on Vaccination Practices on June 25-26. This committee advises the CDC on vaccination recommendations.
What’s behind this discontent? During the Advisory Board meeting, a vote was passed recommending the use of the monoclonal antibody creslovimab to prevent RSV infection in infants, instead of vaccinating pregnant women against RSV. This recommendation came quickly—it was only approved by the FDA 17 days prior—as a preparatory step for the upcoming virus season.
Creslovimab isn’t included in the vaccination schedule approved by the American Academy of Pediatrics. So, is the organization opposing this change in order to protect infants? If not, what’s the reason for their criticism of the committee? It’s worth considering whether politics trumps public health.
In three distinct votes regarding vaccinations for children, pregnant women, and adults, the advisory board also ceased recommendations for seasonal flu vaccines containing mercury-based preservatives. In defending their stance, the American Academy of Pediatrics emphasized that various mercury-free alternatives exist.
Mercury is a well-known toxic substance. The movement to eliminate it from vaccines seems a prudent one. Pediatricians should advocate for children, and using mercury in vaccines isn’t exactly a compelling selling point. After all, mercury has already been taken out of cosmetics, which are less critical than vaccines.
The American Academy of Pediatrics claims there’s no scientific evidence that mercury-containing vaccines cause harm, labeling concerns a misleading issue. But let’s entertain a hypothetical scenario: if we randomly assigned people to two groups, and one enjoyed calamari with, and the other without small amounts of mercury, we’d likely all prefer the mercury-free option, even if health outcomes didn’t differ significantly.
In day-to-day life, while you can’t entirely avoid mercury, it’s wise to minimize exposure, similar to how we approach smoking. Statistically, the risk for lung cancer might not differ between smokers and non-smokers in a small sample, but it’s still advisable to steer clear of cigarette packs.
Pediatricians and family doctors have long faced parents’ anxieties about mercury injections. Their role would be easier if they could assure parents that no vaccines now include mercury-based preservatives. Removing mercury from vaccines might be a small step, but it could help restore some lost trust.
The American Academy of Pediatrics has a history of opposing thorough evaluations of childhood vaccine schedules, despite evidence suggesting a scientific approach is necessary. For example, a study from Denmark on childhood vaccines indicated that live vaccines might be preferable for Danish infants over non-live ones. This suggests the need for a detailed analysis, which could lead to adjustments in the CDC’s vaccine schedule.
Evidence-based healthcare is central to regaining public trust. Most vaccine scientists agree that vaccines must undergo rigorous and ongoing evaluation. If a patient or parent has concerns about a vaccine, those feelings deserve respect and attention. Disregarding people, whether they’re labeled as anti-vaxxers or skeptics, only serves to create further division.
I’ve spent over 20 years studying vaccines and developing safety surveillance systems for the CDC and FDA. Thankfully, issues are rare, but if any do arise, transparency is essential. Reports of side effects from the MMRV vaccine or flawed studies related to HPV vaccines and questionable claims about COVID vaccines exemplify the need for honesty in addressing problems. Failure to acknowledge and tackle such issues could drive vaccine hesitancy further.
I’ve also raised concerns about the composition of the Advisory Committee. When the CDC paused the Johnson & Johnson COVID vaccine in April 2021, I was the sole vaccine scientist advocating against that decision during a critical time. This stance ultimately led the CDC to reverse its decision, yet the AAP did not embrace such pro-vaccine voices in their committee.
The Academy had a representative on the committee, yet they boycotted the June meeting, which is unfortunate. Public health thrives on open dialogue. I’d like to invite the organization to discuss the criticisms of that June meeting openly. Trust in an organization that avoids dialogue is tenuous at best, and I hope they’ll participate.
